SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UK AND EUROPEAN BIOTECHS.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (28)1/31/1997 2:33:00 PM
From: Philip H. Lee   of 64
 
Genelabs (GNLB). 6 3/8 bid, 6 1/2 ask.

Do you have any impressions on Genelabs? They announced a broad patent on transcription factors on 1/22/97, which may clash with a LGND patent. See: biz.yahoo.com

Dupont Merck is also collaborating with GNLB for its Merlin assay. See: biz.yahoo.com

They also have PhaseIII trials for treating lupus with DHEA orally, I think. Please let me know if you have any comments on the stock.

Thanks,
Philip

PS - Apologies to the thread...GNLB doesn't belong to UK or European biotechs, but I couldn't ask the question on the GNLB thread since James hadn't posted there before.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext